Literature DB >> 33674175

Shifts in drug seizures in the United States during the COVID-19 pandemic.

Joseph J Palamar1, Austin Le2, Thomas H Carr3, Linda B Cottler4.   

Abstract

BACKGROUND: Little is known regarding how the COVID-19 pandemic has affected patterns of drug use in the United States. Because drug seizures can serve as a proxy for drug availability, we examined shifts in drug seizures in the US during the pandemic.
METHODS: We examined trends in seizures of marijuana, cocaine, methamphetamine, heroin, and fentanyl within five High Intensity Drug Trafficking Areas-Washington/Baltimore, Chicago, Ohio, New Mexico, and North Florida. Trends were examined for number and total weight of seizures from March 2019 through September 2020 using Joinpoint regression.
RESULTS: Significant decreases in seizures involving marijuana (β = -0.03, P = 0.005) and methamphetamine (β = -0.02, P = 0.026) were detected through April 2020, and then seizures of marijuana (β = 0.10, P = 0.028) and methamphetamine (β = 0.11, P = 0.010) significantly increased through September 2020. The number of seizures involving marijuana and methamphetamine peaked in August 2020, exceeding the highest pre-COVID-19 number of seizures. Fentanyl seizures increased overall (β = 0.05, P < .001), but did not significantly drop during the start of COVID-19, and significant changes were not detected for cocaine or heroin. We also detected a significant increase in weight of marijuana seized from April through September 2020 (β = 0.40, P = .001). The weight of marijuana seized in August 2020 exceeded the highest pre-COVID-19 weight.
CONCLUSION: The COVID-19 pandemic was associated with an immediate decrease in marijuana and methamphetamine seizures, and then increases throughout 2020 with some months exceeding the number (and weights) of seizures from the previous year. More research is warranted to determine the extent to which these seizures reflect changes in drug use.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COVID-19; Drug seizures; Fentanyl; Marijuana; Methamphetamine

Mesh:

Substances:

Year:  2021        PMID: 33674175      PMCID: PMC8026667          DOI: 10.1016/j.drugalcdep.2021.108580

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  16 in total

1.  National Center for Health Statistics Guidelines for Analysis of Trends.

Authors:  Deborah D Ingram; Donald J Malec; Diane M Makuc; Deanna Kruszon-Moran; Renee M Gindi; Michael Albert; Vladislav Beresovsky; Brady E Hamilton; Julia Holmes; Jeannine Schiller; Manisha Sengupta
Journal:  Vital Health Stat 2       Date:  2018-04

2.  Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic.

Authors:  Taylor A Ochalek; Kirk L Cumpston; Brandon K Wills; Tamas S Gal; F Gerard Moeller
Journal:  JAMA       Date:  2020-10-27       Impact factor: 56.272

3.  Self-isolation: A significant contributor to cannabis use during the COVID-19 pandemic.

Authors:  S J Bartel; S B Sherry; S H Stewart
Journal:  Subst Abus       Date:  2020-10-12       Impact factor: 3.716

4.  As Heroin Death Rates Rose, So Did Illicit Drug Seizures.

Authors: 
Journal:  JAMA       Date:  2017-10-10       Impact factor: 56.272

5.  Do drug seizures predict drug-related emergency department presentations or arrests for drug use and possession?

Authors:  Wai-Yin Wan; Don Weatherburn; Grant Wardlaw; Vasilis Sarafidis; Grant Sara
Journal:  Int J Drug Policy       Date:  2015-10-23

6.  Shifts in Drug Use Behavior Among Electronic Dance Music Partygoers in New York During COVID-19 Social Distancing.

Authors:  Joseph J Palamar; Austin Le; Patricia Acosta
Journal:  Subst Use Misuse       Date:  2020-12-14       Impact factor: 2.164

7.  Signal of increased opioid overdose during COVID-19 from emergency medical services data.

Authors:  Svetla Slavova; Peter Rock; Heather M Bush; Dana Quesinberry; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2020-07-10       Impact factor: 4.492

8.  The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020.

Authors:  Justin K Niles; Jeffrey Gudin; Jeff Radcliff; Harvey W Kaufman
Journal:  Popul Health Manag       Date:  2020-10-08       Impact factor: 2.459

9.  Impact of COVID-19 Pandemic on Drug Overdoses in Indianapolis.

Authors:  Nancy Glober; George Mohler; Philip Huynh; Tom Arkins; Dan O'Donnell; Jeremy Carter; Brad Ray
Journal:  J Urban Health       Date:  2020-10-01       Impact factor: 3.671

10.  Opioid Overdose-Related Emergency Department Visits and Accidental Deaths during the COVID-19 Pandemic.

Authors:  Luke N Rodda; Kelsa L West; Kathy T LeSaint
Journal:  J Urban Health       Date:  2020-09-28       Impact factor: 3.671

View more
  11 in total

1.  Trends in seizures of powders and pills containing illicit fentanyl in the United States, 2018 through 2021.

Authors:  Joseph J Palamar; Daniel Ciccarone; Caroline Rutherford; Katherine M Keyes; Thomas H Carr; Linda B Cottler
Journal:  Drug Alcohol Depend       Date:  2022-03-31       Impact factor: 4.852

2.  Tactile Stimulation in Adult Rats Modulates Dopaminergic Molecular Parameters in the Nucleus accumbens Preventing Amphetamine Relapse.

Authors:  D R Rossato; H Z Rosa; J L O Rosa; L H Milanesi; V G Metz; L F D'Àvila; M E Burger
Journal:  Mol Neurobiol       Date:  2022-06-22       Impact factor: 5.682

Review 3.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

Review 4.  Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction.

Authors:  Christopher M Jones; Debra Houry; Beth Han; Grant Baldwin; Alana Vivolo-Kantor; Wilson M Compton
Journal:  Ann N Y Acad Sci       Date:  2021-09-24       Impact factor: 6.499

Review 5.  The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.

Authors:  Daniel Ciccarone
Journal:  Curr Opin Psychiatry       Date:  2021-07-01       Impact factor: 4.787

6.  The Association of Drug-Use Characteristics and Active Coping Styles With Positive Affect in Patients With Heroin-Use Disorder and Methamphetamine-Use Disorder During the COVID-19 Pandemic.

Authors:  Yingying Wang; Jinsong Zuo; Long Wang; Qianjin Wang; Xin Wang; Qian Yang; Hanjing Emily Wu; Colin B Goodman; Dongmei Wang; Tieqiao Liu; Xiangyang Zhang
Journal:  Front Public Health       Date:  2021-12-03

7.  Investigating the impact of COVID-19 on performance and image enhancing drug use.

Authors:  Matthew Dunn; Timothy Piatkowski
Journal:  Harm Reduct J       Date:  2021-12-04

8.  Temporal monitoring of stimulants during the COVID-19 pandemic in Belgium through the analysis of influent wastewater.

Authors:  Tim Boogaerts; Maarten Quireyns; Maarten De Prins; Bram Pussig; Hans De Loof; Catharina Matheï; Bert Aertgeerts; Virginie Van Coppenolle; Erik Fransen; Adrian Covaci; Alexander L N van Nuijs
Journal:  Int J Drug Policy       Date:  2022-04-04

9.  Changes in cannabis use and associated correlates during France's first COVID-19 lockdown in daily cannabis users: results from a large community-based online survey.

Authors:  Salim Mezaache; Cécile Donadille; Victor Martin; Maëla Le Brun Gadelius; Laurent Appel; Bruno Spire; Laelia Briand Madrid; Martin Bastien; Perrine Roux
Journal:  Harm Reduct J       Date:  2022-03-15

Review 10.  Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times.

Authors:  Anh Truc Vo; Thomas Patton; Amy Peacock; Sarah Larney; Annick Borquez
Journal:  Int J Environ Res Public Health       Date:  2022-07-21       Impact factor: 4.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.